Effectiveness of Communication-Focused Pain Neuroscience Education in Chronic Musculoskeletal Pain
Effectiveness of the 'Algo(S)Therapy' Pain Neuroscience Education Program Emphasizing Physiotherapists' Communication Skills in Patients With Chronic Musculoskeletal Pain: A Randomized Controlled Trial
1 other identifier
interventional
90
1 country
1
Brief Summary
This randomized controlled trial aims to evaluate the effectiveness of the "Algo(S)Therapy" Pain Neuroscience Education (PNE) program in patients with chronic musculoskeletal pain. The study will assess whether the integration of communication skills training for physiotherapists enhances the outcomes of PNE. Participants will be randomly assigned to one of three groups: (1) PNE with communication-focused delivery, (2) PNE without communication emphasis, or (3) standard- usual physiotherapy care. The primary objective is to determine whether PNE combined with enhanced communication skills leads to greater improvements in pain, function, and psychosocial outcomes compared to the other interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2025
CompletedFirst Posted
Study publicly available on registry
June 3, 2025
CompletedStudy Start
First participant enrolled
June 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 30, 2026
May 7, 2026
April 1, 2026
1.2 years
May 22, 2025
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Numeric Pain Rating Scale - NPRS
Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), where participants rate their average pain on a scale from 0 (no pain) to 10 (worst imaginable pain). The measure will be used to determine the effectiveness of each intervention in reducing chronic musculoskeletal pain.
Baseline, Post-intervention (Week 5), and 3-Month Follow-Up
Secondary Outcomes (14)
Central Sensitisation Inventory (CSI)
Baseline, Post-intervention (Week 5), and 3-Month Follow-Up
Pain Catastrophizing Scale (PCS)
Baseline, Post-intervention (Week 5), and 3-Month Follow-Up
Tampa Scale for Kinesiophobia (TSK)
Baseline, Post-intervention (Week 5), and 3-Month Follow-Up
Pain Sensitivity Questionnaire (PSQ)
Baseline, Week 5, and 3-Month Follow-Up
Pain Self-Efficacy Questionnaire (PSEQ)
Baseline, Week 5, and 3-Month Follow-Up
- +9 more secondary outcomes
Study Arms (3)
PNE + Communication Skills
EXPERIMENTALParticipants in this group will receive an individualized Pain Neuroscience Education (PNE) program plus usual physiotherapy care delivered by physiotherapists who completed the full "Algo(S)Therapy" training. This training included education in the neurophysiology of pain, assessment and management of chronic musculoskeletal pain, as well as the development and application of communication skills. The communication training focused on strategies such as motivational interviewing, empathy, active listening, and patient-centered interaction specifically tailored for individuals with chronic pain. The intervention will be administered over a 5-week period, with 2 sessions per week.
PNE without Communication Training
EXPERIMENTALParticipants in this group will receive an individualized Pain Neuroscience Education (PNE) intervention plus usual physiotherapy care, delivered by physiotherapists who completed only the pain neurophysiology and clinical management components of the "Algo(S)Therapy" program. These physiotherapists did not receive any formal training in communication skills, such as motivational interviewing or empathy techniques. The intervention will be administered over a 5-week period, with 2 sessions per week.
Usual Physiotherapy Treatment
ACTIVE COMPARATORParticipants in this group will receive usual physiotherapy care. Physiotherapists in this group have not received any training in Pain Neuroscience Education or communication techniques related to chronic pain management. No components of the "Algo(S)Therapy" program will be applied in this group.
Interventions
This intervention includes individualized physiotherapy based on a Pain Neuroscience Education (PNE) framework delivered by physiotherapists who completed the full "Algo(S)Therapy" training program. The training includes education in the neurophysiology of pain, clinical reasoning for chronic musculoskeletal pain management, and structured communication skills development (e.g., motivational interviewing, empathy, active listening). The intervention is delivered twice per week over 5 weeks (10 sessions total).
A structured PNE program focusing on the neurophysiology and clinical management of chronic musculoskeletal pain. Delivered by physiotherapists trained only in the scientific modules of the "Algo(S)Therapy" program. Does not include communication skills training. Includes 10 sessions (2/week for 5 weeks), alongside standard physiotherapy care.
Usual care based on medical referral and physiotherapy assessment. Delivered by physiotherapists who have not received training in Pain Neuroscience Education or communication techniques. No components of the "Algo(S)Therapy" program are included.
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 65 years
- Diagnosis of chronic musculoskeletal pain in the lumbar spine, cervical spine, shoulder, or knee
- Pain duration longer than 3 months
- Pain intensity ≥3/10 on the Numeric Pain Rating Scale (NPRS)
- Pain present most days of the week
- Able to understand and speak the Greek language
You may not qualify if:
- Acute pain in any body region
- Neurological disorders or myopathies
- Chronic pain of non-musculoskeletal origin
- Active cancer diagnosis
- History of trauma, fractures, or surgery in the past year
- Pregnancy
- Diagnosis of fibromyalgia
- Cognitive impairments affecting communication or completion of questionnaires
- Current use of corticosteroid medication
- Participation in other treatment programs or alternative therapies during the study period
- Concurrent enrollment in another clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Physiotherapy Department, University of Thessaly, Greece
Lamia, Central Greece, 35100, Greece
Study Officials
- STUDY CHAIR
Eleni Kapreli, Professor
Physiotherapy Department, University of Thessaly, Greece
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Candidate
Study Record Dates
First Submitted
May 22, 2025
First Posted
June 3, 2025
Study Start
June 17, 2025
Primary Completion (Estimated)
August 30, 2026
Study Completion (Estimated)
August 30, 2026
Last Updated
May 7, 2026
Record last verified: 2026-04